Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2014 2
2015 9
2016 6
2017 2
2018 5
2019 4
2020 5
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation.
Sadras I, Kerem E, Livnat G, Sarouk I, Breuer O, Reiter J, Gileles-Hillel A, Inbar O, Cohen M, Gamliel A, Stanleigh N, Gunawardena T, Bartlett C, Gonska T, Moraes T, Eckford PDW, Bear CE, Ratjen F, Kerem B, Wilschanski M, Shteinberg M, Cohen-Cymberknoh M. Sadras I, et al. Among authors: sarouk i. J Cyst Fibros. 2023 Nov;22(6):1062-1069. doi: 10.1016/j.jcf.2023.06.001. Epub 2023 Jun 16. J Cyst Fibros. 2023. PMID: 37331863
Spontaneous pneumothorax-When do we need to intervene?
Ashkenazi M, Bak A, Sarouk I, Bar Aluma BE, Dagan A, Bezalel Y, Vilozni D, Efrati O. Ashkenazi M, et al. Among authors: sarouk i. Clin Respir J. 2021 Sep;15(9):967-972. doi: 10.1111/crj.13400. Epub 2021 May 31. Clin Respir J. 2021. PMID: 33998780
Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis.
Ramalho AS, Fürstová E, Vonk AM, Ferrante M, Verfaillie C, Dupont L, Boon M, Proesmans M, Beekman JM, Sarouk I, Vazquez Cordero C, Vermeulen F, De Boeck K; Belgian Organoid Project. Ramalho AS, et al. Among authors: sarouk i. Eur Respir J. 2021 Jan 5;57(1):1902426. doi: 10.1183/13993003.02426-2019. Print 2021 Jan. Eur Respir J. 2021. PMID: 32747394 Free article.
Phenotypic and molecular characteristics of CF patients carrying the I1234V mutation.
El Bar Aluma B, Sarouk I, Senderowitz H, Cohen-Cymberknoh M, Khazanov N, Dagan A, Bezalel Y, Ashkenazi M, Keler S, Efrati O. El Bar Aluma B, et al. Among authors: sarouk i. Respir Med. 2020 Aug-Sep;170:106027. doi: 10.1016/j.rmed.2020.106027. Epub 2020 Jun 3. Respir Med. 2020. PMID: 32843167 Free article.
Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experience.
Dagan A, Cohen-Cymberknoh M, Shteinberg M, Levine H, Vilozni D, Bezalel Y, Bar Aluma BE, Sarouk I, Ashkenazi M, Lavie M, Tsabari R, Blau H, Kerem E, Bentur L, Efrati O, Livnat G. Dagan A, et al. Among authors: sarouk i. Respir Med. 2017 Oct;131:225-228. doi: 10.1016/j.rmed.2017.08.026. Epub 2017 Sep 1. Respir Med. 2017. PMID: 28947035 Free article.
The Value of Measuring Inspiratory Capacity in Subjects With Cystic Fibrosis.
Vilozni D, Dagan A, Lavie M, Sarouk I, Bar-Aluma BE, Ashkenazi M, Mendelovich SL, Betzalel Y, Efrati O. Vilozni D, et al. Among authors: sarouk i. Respir Care. 2018 Aug;63(8):981-987. doi: 10.4187/respcare.05920. Epub 2018 Jul 17. Respir Care. 2018. PMID: 30018173 Free article.
32 results